Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Prospective Study on HIV-related Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
T-Cell Depleted Double UCB for Refractory AML
- Status
- TERMINATED
- Phase
- PHASE2
Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
The Efficacy and Safety of Tacrolimus in Treated Refractory Focal Segmental Glomerulosclerosis
- Status
- TERMINATED
- Phase
- NA
Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial
- Status
- TERMINATED
- Phase
- PHASE3
Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2